23
In August of 2015, the Food and Drug Administration (FDA) approved its first 3D-printed pharmaceutical drug. It’s not surprising that almost immediately, attorneys began to warn of two potential legal issues; one concerning product liability, and the other dealing with intellectual property. Aprecia, the company that “prints” the drug known as Spritam, uses a 3D …